The PI3Kδ selective inhibitor AS2541019 suppresses donor-specific antibody production in rat cardiac and non-human primate renal allotransplant models
Takanori Marui(Astellas Pharma (Japan)), Tatsuaki Morokata(Astellas Pharma (Japan)), Susumu Tsujimoto, Hidehiko Fukahori(Astellas Pharma (Japan)), Misato Ito(Fukushima Medical University), Yoko Kaneko(Keio University), Masashi Maeda(Astellas Pharma (Japan))
Cited by 5
Related Papers
NAK is an IκB kinase-activating kinase
|Nature|2000|374
Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model
|Gene Therapy|1999|117
Role of Human Cds1 (Chk2) Kinase in DNA Damage Checkpoint and Its Regulation by p53
|Journal of Biological Chemistry|1999|100
Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study
|Lara D. Veeken|2011|89
Phosphorylation of the N-terminal portion of tyrosine hydroxylase triggers proteasomal digestion of the enzyme
|Biochemical and Biophysical Research Communications|2011|68